Catherine Luke

906 total citations
24 papers, 631 citations indexed

About

Catherine Luke is a scholar working on Internal Medicine, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Catherine Luke has authored 24 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Internal Medicine, 14 papers in Hematology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Catherine Luke's work include Venous Thromboembolism Diagnosis and Management (19 papers), Blood Coagulation and Thrombosis Mechanisms (14 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Catherine Luke is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (19 papers), Blood Coagulation and Thrombosis Mechanisms (14 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Catherine Luke collaborates with scholars based in United States, Sweden and United Kingdom. Catherine Luke's co-authors include Peter K. Henke, Megan Elfline, Thomas W. Wakefield, Kristopher B. Deatrick, Vikram Sood, He Meng, Jason S. Knight, David J. Pinsky, Srilakshmi Yalavarthi and Yogendra Kanthi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Catherine Luke

21 papers receiving 621 citations

Peers

Catherine Luke
Megan Elfline United States
Sherin Alias Austria
Jian-Ming Gu United States
Sara B. Hendrickson United States
P H Reitsma Netherlands
Megan Elfline United States
Catherine Luke
Citations per year, relative to Catherine Luke Catherine Luke (= 1×) peers Megan Elfline

Countries citing papers authored by Catherine Luke

Since Specialization
Citations

This map shows the geographic impact of Catherine Luke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Luke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Luke more than expected).

Fields of papers citing papers by Catherine Luke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Luke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Luke. The network helps show where Catherine Luke may publish in the future.

Co-authorship network of co-authors of Catherine Luke

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Luke. A scholar is included among the top collaborators of Catherine Luke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Luke. Catherine Luke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamaguchi, Adriana, Sylviane Lambert, Catherine Luke, et al.. (2023). The oxylipin analog CS585 prevents platelet activation and thrombosis through activation of the prostacyclin receptor. Blood. 142(18). 1556–1569. 9 indexed citations
2.
Andrea, T., Megan Elfline, Catherine Luke, et al.. (2023). Experimental venous thrombus resolution is driven by IL-6 mediated monocyte actions. Scientific Reports. 13(1). 3253–3253. 8 indexed citations
3.
Bamezai, Sharika, Kevin Mangum, Catherine Luke, et al.. (2023). Abstract 554: Monocyte Toll-like Receptor 4 (tlr4) Signaling Is Essential For Post Thrombotic Upa Expression. Arteriosclerosis Thrombosis and Vascular Biology. 43(Suppl_1).
4.
DeRoo, Elise, Mitri K. Khoury, Ting Zhou, et al.. (2022). Investigating the role of receptor interacting protein kinase 3 in venous thrombosis. SHILAP Revista de lepidopterología. 3. 365–378. 1 indexed citations
5.
Dowling, Abigail R., et al.. (2022). Modulation of interleukin-6 and its effect on late vein wall injury in a stasis mouse model of deep vein thrombosis. SHILAP Revista de lepidopterología. 3. 246–255. 5 indexed citations
6.
Andrea, T., Elizabeth Andraska, Yogendra Kanthi, et al.. (2016). Gram-Negative Pneumonia Alters Large-Vein Cell-Adhesion Molecule Profile and Potentiates Experimental Stasis Venous Thrombosis. Journal of Vascular Research. 53(3-4). 186–195. 7 indexed citations
7.
Gallagher, Katherine, T. Andrea, Megan Elfline, et al.. (2016). Alterations in macrophage phenotypes in experimental venous thrombosis. Journal of Vascular Surgery Venous and Lymphatic Disorders. 4(4). 463–471. 17 indexed citations
8.
Meng, He, Srilakshmi Yalavarthi, Yogendra Kanthi, et al.. (2016). In Vivo Role of Neutrophil Extracellular Traps in Antiphospholipid Antibody–Mediated Venous Thrombosis. Arthritis & Rheumatology. 69(3). 655–667. 169 indexed citations
9.
Dewyer, Nicholas A., Catherine Luke, Megan Elfline, et al.. (2015). Intact Toll-like receptor 9 signaling in neutrophils modulates normal thrombogenesis in mice. Journal of Vascular Surgery. 64(5). 1450–1458.e1. 33 indexed citations
10.
Comerota, Anthony J., et al.. (2015). A histological and functional description of the tissue causing chronic postthrombotic venous obstruction. Thrombosis Research. 135(5). 882–887. 38 indexed citations
11.
Farris, Diana, et al.. (2015). Efficacy of Apixaban on Thrombus Resolution and Anti-Inflammation in a Murine Model of Acute Deep Venous Thrombosis. Journal of Vascular Surgery Venous and Lymphatic Disorders. 4(1). 139–140. 1 indexed citations
12.
Luke, Catherine, et al.. (2014). Standardisierung der ARFI Lebermessungen: Konvexschallköpfe 6C1HD vs. 4C1 und Lagerung der Probanden. Ultraschall in der Medizin - European Journal of Ultrasound. 35(S 01).
13.
Henke, Peter K., et al.. (2013). Human Chronic Post-Thrombotic Intraluminal Venous Obstruction Involves Neovascularization. Journal of Vascular Surgery Venous and Lymphatic Disorders. 2(1). 110–110. 2 indexed citations
14.
Deatrick, Kristopher B., T. Andrea, Catherine Luke, et al.. (2013). Matrix metalloproteinase-9 deletion is associated with decreased mid-term vein wall fibrosis in experimental stasis DVT. Thrombosis Research. 132(3). 360–366. 37 indexed citations
15.
Deatrick, Kristopher B., Catherine Luke, Megan Elfline, et al.. (2013). The effect of matrix metalloproteinase 2 and matrix metalloproteinase 2/9 deletion in experimental post-thrombotic vein wall remodeling. Journal of Vascular Surgery. 58(5). 1375–1384.e2. 40 indexed citations
16.
Deatrick, Kristopher B., Megan Elfline, Catherine Luke, et al.. (2010). Postthrombotic vein wall remodeling: Preliminary observations. Journal of Vascular Surgery. 53(1). 139–146. 66 indexed citations
17.
Sood, Vikram, Catherine Luke, Erin Miller, et al.. (2010). Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism. Thrombosis and Haemostasis. 104(12). 1174–1183. 28 indexed citations
18.
Dewyer, Nicholas A., Vikram Sood, Erin Lynch, et al.. (2007). Plasmin Inhibition Increases MMP-9 Activity and Decreases Vein Wall Stiffness During Venous Thrombosis Resolution. Journal of Surgical Research. 142(2). 357–363. 29 indexed citations
19.
Rectenwald, John E., Kristopher B. Deatrick, Erin Lynch, et al.. (2006). Experimental pulmonary embolism: Effects of the thrombus and attenuation of pulmonary artery injury by low-molecular-weight heparin. Journal of Vascular Surgery. 43(4). 800–808. 23 indexed citations
20.
Eagleton, Matthew J., Peter K. Henke, Catherine Luke, et al.. (2002). Inflammation and intimal hyperplasia associated with experimental pulmonary embolism. Journal of Vascular Surgery. 36(3). 581–588. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026